Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Charles River

This page shows the latest Charles River news and features for those working in and with pharma, biotech and healthcare.

EFPIA pledges to boost drug access throughout Europe

EFPIA pledges to boost drug access throughout Europe

According to analysis by Charles River Associates, there are ten interrelated factors that cause barriers and delays in patients getting access to new medicines.

Latest news

  • Mid-sized European biotechs ‘need more support’ Mid-sized European biotechs ‘need more support’

    In a new report commissioned by EFPIA and compiled by Charles River Associates (CRA), the authors were asked to explore the extent to which barriers to growth exist, and to what

  • Galapagos divests CRO operations to pursue biotech path Galapagos divests CRO operations to pursue biotech path

    The company said the proceeds from the 134m deal with Charles River Laboratories would be used to progress a pipeline that includes the phase 2 JAK1 (Janus kinase 1) inhibitor GLPG0634. ... The transition will be led by the CEO of Galapagos Services

  • Taking contract research’s pulse Taking contract research’s pulse

    James Foster, CEO of early-stage R&D-focused CRO Charles River Laboratories, has a different view, however, saying that the company currently makes around 25 per cent of its sales

  • Charles River ties up with Theorem for non-clinical testing

    CROs form strategic alliance in bioanalysis, immunogenicity and immunology. Charles River Laboratories and Theorem Clinical Research have formed a strategic alliance to provide their clients with a new non-clinical testing ... Alan Bartlett, executive

  • Solid Foundations

    But how do outsiders get a look in? Nathan Waller, a senior marketing manager with global CRO, Charles River Laboratories, believes the only thing stopping marketing from adopting a higher profile ... It is up to companies like Charles River and

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Capitalising on new drug opportunities in mid-income countries

    Opportunities for new drugs in mid-income countries have come under the spotlight, following a survey by Charles River Associates (CRA), which says that more could be done to increase the

  • Charles River

    For more than 60 years, Charles River has provided tailored research models and laboratory animal support services, as well as preclinical and clinical support services, to help our global partners accelerate ... Telephone:800.3195.3430. Address:.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Quick links